HER2 gene amplification in breast cancer is associated with increased cell proliferation, cell motility, tumor invasiveness, progressive regional and distant metastases, accelerated angiogenesis, and reduced apoptosis (9, 10). Here, ERBB2 is linked to breast carcinoma.